Improving support for caregivers of patients with advanced Alzheimer's disease
Adapting and Implementing the I-HoME Intervention in Caregivers of Patients With ADRD
This study is testing a new technology-based support program for family caregivers of patients with advanced Alzheimer's disease to see if it helps them manage end-of-life issues better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 15 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06488157 on ClinicalTrials.gov |
What this trial studies
This study aims to pilot test the I-HoME intervention, which focuses on enhancing the management of end-of-life issues through technology for family caregivers of patients with advanced Alzheimer's Disease and related dementias. The intervention will be adapted specifically for this population, and data will be collected to assess its feasibility and acceptability among caregivers. By evaluating the effectiveness of this intervention, the study seeks to provide valuable insights into improving caregiver support.
Who should consider this trial
Good fit: Ideal candidates for this study are English-speaking caregivers aged 18 years or older who provide care to patients with advanced Alzheimer's disease.
Not a fit: Patients who are non-English speaking or outside the specified age range may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce caregiver burden and improve the quality of care for patients with advanced Alzheimer's disease.
How similar studies have performed: Other studies have shown success with similar caregiver interventions, indicating potential for positive outcomes in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years old and \< 100 years * English speaking * Providing care to an ADRD patient who is age ≥ 65 years old and \< 105 years who is a stage 7a-f on the Functional Assessment Staging Tool (FAST) scale Exclusion Criteria: * Non-English speaking * \<18 years old or \>100 years old
Where this trial is running
New York, New York
- Weill Cornell Medicine — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Veerawat Phongtankuel, MD — Weill Medical College of Cornell University
- Study coordinator: Veerawat Phongtankuel, MD
- Email: vep9012@med.cornell.edu
- Phone: 2127467000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.